|Articles|April 27, 2023
Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke (INTERPHEX 2023)
James Rorke, vice-president, operations, Steriline North America, discusses the benefits of automation in fill/finish operations.
Advertisement
James Rorke, vice-president, operations, Steriline North America, discusses the advantages of automation in fill/finish, particulary for low volume, high quaility products such as cell and gene therapies, for which minimizing product loss is crucial.
For more INTERPHEX 2023 video content, check
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
5
